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The 3D structure of the bacterial peptidoglycan, the major constit-
uent of the cell wall, is one of the most important, yet still
unsolved, structural problems in biochemistry. The peptidoglycan
comprises alternatingN-acetylglucosamine (NAG) andN-acetylmu-
ramic disaccharide (NAM) saccharides, the latter of which has a
peptide stem. Adjacent peptide stems are cross-linked by the
transpeptidase enzymes of cell wall biosynthesis to provide the cell
wall polymer with the structural integrity required by the bacte-
rium. The cell wall and its biosynthetic enzymes are targets of
antibiotics. The 3D structure of the cell wall has been elusive
because of its complexity and the lack of pure samples. Herein we
report the 3D solution structure as determined by NMR of the
2-kDa NAG-NAM(pentapeptide)-NAG-NAM(pentapeptide) syn-
thetic fragment of the cell wall. The glycan backbone of this
peptidoglycan forms a right-handed helix with a periodicity of
three for the NAG-NAM repeat (per turn of the helix). The first two
amino acids of the pentapeptide adopt a limited number of
conformations. Based on this structure a model for the bacterial cell
wall is proposed.
murein sacculus  bacterial envelope
The peptidoglycan scaffold of the bacterial cell wall is arepeating N-acetylglucosamine (NAG)-N-acetylmuramic
disaccharide (NAM) [NAG-(-1,4)-NAM] having a pentapep-
tide attached to the D-lactyl moiety of each NAM. This pen-
tapeptide stem participates in an interglycan cross-linking reac-
tion, thus creating the cell wall polymer. In contrast to the two
other -1,4-linked glycan biopolymers, cellulose (repeating glu-
cose) (1–4) and chitin (repeating NAG) (5–7) for which the 3D
structure is solved, the structure of the bacterial cell wall has
remained elusive because of its complexity and the lack of pure
and discrete segments for structural study (8–18). Herein we
describe the 3D structure, determined in aqueous solution by
NMR, of a 2-kDa synthetic NAG-NAM(pentapeptide)-NAG-
NAM(pentapeptide) tetrasaccharide cell wall segment. The
defining aspect of this structure is an ordered, right-handed
helical saccharide conformation corresponding to three NAG-
NAM pairs per turn of the helix. The structure of this pepti-
doglycan segment is the basis for a proposal for the structure of
the bacterial cell wall polymer.
Results and Discussion
3D Structure of the Peptidoglycan. Because of the critical signifi-
cance of the cell wall to bacterial survival, and the exploitation
of the cell wall biosynthetic enzymes for the chemotherapeutic
intervention of infections, many experimental and theoretical
studies have addressed the cell wall structure. Despite diffraction
studies carried out 30 years ago on cell wall extracted from
bacteria, which strongly suggested that the peptidoglycan poly-
mer possessed regular order (11), the 3D structure of the cell
wall is not known. An excellent account of the historical devel-
opment of the hypotheses for the cell wall structure is given by
Dmitriev, Toukach, and Ehlers in their recent review (18). The
major reason for the lack of progress is the absence of a pure
fragment of the cell wall, having both the peptide and disaccha-
ride components of the peptidoglycan, for structural investiga-
tion. To address this limitation we completed the 37-step syn-
thesis of such a segment (1, Fig. 1A) (19). The structure of this
segment replicates a strand of the Gram-positive peptidoglycan
(which has a L-Ala-D--Glu-L-Lys-D-Ala-D-Ala pentapeptide
stem), but replacement of the L-lysine by diaminopimelate would
replicate the Gram-negative peptidoglycan structure. Com-
pound 1 is sufficiently large to adopt discrete structure in
solution, yet sufficiently small as to allow detailed NMR analysis
at natural isotopic abundance.
Complete 1H, 13C, and 15N assignments for 1 were made by
correlation NMR (double quantum filtered-COSY, 1H-total
correlated spectroscopy, and 13C and 15N heteronuclear sequen-
tial quantum correlation) methods. A representative through-
bond coupling experiment is shown in Fig. 2. A series of nuclear
Overhauser effect (NOE) experiments were used to identify
interatomic distance correlations that provided constraints used
to solve the compound structure. Integrated peak volumes for
each resonance, obtained at both 100- and 400-ns mixing times,
were used to develop a build-up curve for subsequent distance
restraints. A total of 63 independent 1H–1H NOE pairs (Tables
1 and 2, which are published as supporting information on the
PNAS web site) were identified. Among these, 6 occur within the
NAG-NAM disaccharide (3 NOEs between the NAG H-1 and
NAM H-3 and 3 between the NAG H-1 and NAM H-4), 16
between the peptide and saccharide hydrogens, 13 between the
peptide stem hydrogens, and the remainder between intrasac-
charide hydrogens.
With the NOE restraints in place, a series of annealing
molecular dynamics trajectories identified an ensemble of 20
conformations for 1 (Fig. 1B). In these conformations the two
middle saccharides (NAM1–NAG2) show greater stability com-
pared with the terminal (NAG1 and NAM2) saccharides. Three
pairs of glycosidic dihedral angles define the tetrasaccharide
conformation (where  is the H1-C1-O4-C4 dihedral and  is the
C1-O4-C4-H4 dihedral). For the conformations shown in Fig. 2B
for 1, the three pairs of dihedral angles are (from left to right)
1  69  1°, 1  12  2°; 2  68  2°, 2  17  1°; and
3 66 8°, 3 16 7°. These angles are consistent with the
preferred orientation of the C4 carbon of NAM relative to C2 and
the ring oxygen of NAG along the C1OO4 bond as predicted by
the exo-anomeric effect (20). In contrast to the defined tetrasac-
charide conformation, the two pentapeptide stems show greater
mobility. The D-Lac, L-Ala, and D-Glu of each adopt a limited
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number of conformers, whereas the L-Lys-D-Ala-D-Ala termini
are disordered (that is, no NOE contacts are observed).
Early models ascribed a chitin-like structure to the bacterial
peptidoglycan (8). Hence, the hydrogen-bond pattern that is
observed in chitin was also presumed to occur in the bacterial
peptidolgycan. In particular, a 2.7-Å intersaccharide hydrogen
bond occurs in chitin between the pyranose oxygen and the C-3
hydroxyl moiety of the adjacent NAG rings. The structure
determined for compound 1 shows, however, a distance between
the pyranose oxygen of NAM and the C-3 hydroxyl oxygen of
NAG of 3.4 Å. This distance is too long to be an important
structural interaction. A second possible interaction in the
peptidoglycan structure was proposed by Tipper (21). This
structure features a hydrogen bond between the C-6 hydroxyl of
NAG and the carbonyl oxygen of the lactyl group in NAM. The
separation between these atoms in the 20 conformers of com-
pound 1 is 8.2 Å, precluding the presence of this hydrogen bond.
A third possible interaction was suggested by Knox and Murthy
(22). This structure is characterized by a hydrogen bond between
the lactyl moiety and the NAM acetamido nitrogen. This
distance in the NMR structure of compound 1 is 5.1 Å. Hence,
and in contrast to each of these proposals, the solution structure
for 1 has no important intersaccharide hydrogen bonds contrib-
uting to its solution structure. The solution structure of 1 is set
apart from the known structures of chitin and cellulose, where
intersaccharide hydrogen bonds impart stability to their struc-
tures. The importance of water molecules in structures of
carbohydrates in solutions cannot be discounted (23). We ac-
knowledge that specific water molecules in the structure of 1
might bridge heteroatoms to afford additional stability.
Structure of the Peptidoglycan Oligomer. The average length of the
peptidoglycan of the Gram-negative Escherichia coli strain W7 is
nine NAG-NAM repeats (24–26). The defined and repeating
glycosidic torsion angles of 1 (two NAG-NAM repeats) allows
Fig. 2. The 13C heteronuclear sequential quantum correlation spectrum of 1
showing 13C correlations for the 1H resonances between  2.8 and 5.0. This
600-MHz (with respect 1H) spectrum was obtained at 298 K by using a 15-mM
solution of 1 in 100% D2O. Spectral features folded in the carbon dimension
are identified by *.
Fig. 1. Chemical structure and solution conformation of the peptidoglycan segment. (A) Chemical structure of compound 1. (B) NMR structure of the synthetic
segment 1 of the cell wall, shown as a stereoview of 20 superimposed conformers. The disordered segments of the peptide stems (the L-Lys-D-Ala-D-Ala termini)
are omitted for clarity. The conformers are depicted in capped sticks representation with O atoms in red, N atoms in blue, and C atoms in yellow.








the prediction of the structure of the longer peptidoglycan. The
result is a right-handed helix having three NAG-NAM repeats
per turn (Fig. 3). Three-fold symmetry with respect to the
peptide stems is seen with respect to the axis of the helix. This
structure contrasts sharply with that of -chitin, which has a
2-fold screw axis in which the planes of the saccharide rings
orient at 180° to each other. This symmetry signifies that a
lactyl–pentapeptide stem, attached to C-3 on the alternating
saccharides of a peptidoglycan in the chitin conformation, will
orient these stems to only one side of the axis. This outcome also
applies to a cellulose glycan structure, as its structure is identical
to that of chitin.
Structure of the Bacterial Cell Wall. The implication of the 3-fold
symmetry adopted by the peptidoglycan is profound. Each strand
of the peptidoglycan is predisposed for cross-linking to a max-
imum of three neighboring peptidoglycan strands. The extent of
peptidoglycan cross-linking observed in bacteria is variable, and
forE. coli is estimated to be40% (26, 27). Hence not all strands
are expected to cross-link. Using the expectation of incomplete
cross-linking, the in silico generation of a larger cell wall segment
was done. The result is the honeycomb pattern shown in Fig. 4
A and B. The smallest pores (three intact cross-links) are 70 Å
across. This pore is large enough to contain, within its perimeter,
the enzyme catalysts of its biosynthesis. As is evident from Fig.
4B, missing cross-links result in larger pores and missing strands
result in even larger pores. The approximate diameter of a pore
with one absent cross-link is 120 Å. This honeycomb pattern
agrees well with atomic force microscopic images of the Gram-
positive bacterium Staphylococcus aureus, which show a surface
dotted with pores ranging in size from 50 to 500 Å (28).
The fundamental events of peptidoglycan biosynthesis are
transglycosylase-catalyzed glycan lengthening and transpepti-
dase-catalyzed peptidoglycan cross-linking. These two reactions
are often catalyzed by a single membrane-bound bifunctional
enzyme, called the class A penicillin-binding protein (PBP)
because of the ability of penicillin to inactivate (by irreversible
acylation) its transpeptidase active site. The structure of this
enzyme suggests that the two active sites of this PBP, the
membrane–proximal transglycosylase and the membrane–distal
transpeptidase, may be separated by as much as 70–100 Å
(29–31). The membrane proximity of the transglycosylase active
site suggests that for a given peptidoglycan segment glycan strand
extension precedes transpeptidase cross-linking. This presump-
tion is supported by the observation (in the Gram-positive R61
transpeptidase) of two channels that cross the transpeptidase
active site so as to accommodate entering and departing glycans
for the two separate strands undergoing the cross-link (31). The
20-Å distance between the two grooves is consistent with this
model.
Fig. 3. The [NAG-NAM]8 octamer construct derived from the NMR structure
of 1. (A) Stereoview of a representative [NAG-NAM]8 conformer, shown in
capped-stick representation (O, N, and C are shown in red, blue, and yellow,
respectively). (B) Solvent-accessible Connolly surface representation with the
glycan backbone shown in orange and the peptide in green for the same
perspective shown in A. (C) Stereoview of this construct seen from above
(down the helical axis), shown as a solvent-accessible Connolly surface with
the same the color coding as in B.
Fig. 4. Structure of the polymeric peptidoglycan segment. (A) Schematic of
the top view of the structure of the cell wall with each peptidoglycan strand
represented as a three-pronged star, mimicking the image shown in B. (B and
C) Top (B) and side (C) views of the extended model of the structure of the cell
wall. A Connolly solvent-accessible surface is used, showing the glycan strands
in orange and the peptide stems in green (as also depicted in Fig. 3B for an
individual strand of peptidoglycan). The top view is shown to a depth of eight
NAG-NAM repeats, and double-headed arrows span a small and a larger pore.
The longest strands in the side view are also eight NAG-NAM repeats. For
reference, as determined by Matiaset al. (42) the approximate thickness of the
cell wall components for E. coli are: plasma membrane, 58 Å; peptidoglycan,
64 Å; periplasm, 210 Å; outer membrane (having a truncated lipopolysaccha-
ride), 69 Å.
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An additional argument for the plausibility of our cell wall
structure is provided by the AcrABTolC Gram-negative efflux
complex. The TolC channel protein of this complex is a needle-
shaped protein with distinctive, and adjacent, outer membrane
and periplasmic domains (32–34). The periplasmic domain of the
TolC channel protein complexes to the tip of the AcrAB efflux
enzyme, forming an efflux channel between the cytoplasm and
the exterior of the bacterium (35, 36). The diameter of the
peptidoglycan-interacting segment of the TolC protein is 70 Å
(34, 37). As Fig. 5 shows, the TolC protein is perfectly shaped for
insertion into the 70-Å pore of the cell wall model depicted in
Fig. 4B.
The Orientation of the Bacterial Cell Wall.Weare acutely aware of an
assumption inherent to the preceding discussion. The customary
‘‘textbook’’ depiction of the glycan strand is an orientation that is
parallel to the bacterial outer membrane surface (13–18). The
preceding discussion, however, presumes that the glycan strand
orientation is orthogonal to the membrane. Although Vollmer and
Holtje (15) argue that the parallel model better accommodates the
structural requirements for Gram-negative cell division, cogent
arguments that favor the perpendicular orientation are given by
Dmitriev et al. (18, 38–40). The increasingly sophisticated obser-
vations of Beveridge and colleagues (41–43) on bacterial substruc-
ture are consistent with both orientations (28). Although the
experimental data used for the construction of ourmodel clearly do
not distinguish between the two, we regard an orthogonal glycan
orientation as especially attractive from the perspective of Fig. 5 on
the basis of the following circumstantial arguments. The model
suggests a straightforward basis for the creation of small to large
pores on the bacterial surface that visually agrees with atomic force
microscopic imaging of the surface of the cell wall of bacteria (28).
The model is consistent with the spatial location of the penicillin-
binding protein transpeptidase active site in the periplasm (29–31).
Themodel of Fig. 5 is consistent with the average glycan length (12)
and experimental width for the peptidoglycan (42). The direct
embrace of the model of the TolC protein is consistent with
fundamental agreement between the protein diameter and the
smallest pore diameter of the model, while also suggesting how the
peptide cross-links of the peptidoglycanmay hold the TolC protein,
via its helical equatorial loop domains (32, 33, 37) within the
peptidoglycan.
The structure of the bacterial peptidoglycan has been the
subject of intense study and speculation for the past 40 years. The
Fig. 5. Stereoviews from the side of (A) and above (B) the crystal structure of TolC outer-membrane channel embedded into a pore of the cell wall depicted
in Fig. 4. The TolC protein is shown in ribbon and surface representations by using a purple solvent-accessible Connolly surface. The protruding TolC -barrel
domain (shown in ribbon) is fully embedded into the outer-membrane bilayer of the Gram-negative bacterium. As the peptidoglycan is in direct contact with
the inner leaflet of the outer membrane bilayer, the juxtaposition of the TolC within the peptidoglycan is reasonable. The glycan chains are eight NAG-NAM
repeats in length.








peptidoglycan structures of Figs. 3–5 incorporate the solution
structure of 1, are consistent with expectations for architectural
strength, and are attractive by several experimental criteria that
define the cell wall structure. This structure is presented as a
compelling hypothesis to guide further study of peptidoglycan
biosynthesis and peptidoglycan interaction with the lipid and
protein ensembles of the bacterial cell wall.
Methods
NMR Spectroscopy. NMR spectra were acquired by using a
15-mM solution of 1 (Chemical Abstracts Service Registry No.
678159-02-9) in either 9:1 H2OD2O or D2O, in the absence of
added salt or buffer. The pH of these solutions was 4.4. NMR
spectra were acquired at 25°C by using pulsed-field gradients
on the following spectrometers: Varian INOVA 600-MHz
spectrometer (Wayne State University), a Bruker (Billerica,
MA) AVANCE 700-MHz spectrometer (Wayne State Univer-
sity), and a Varian INOVA 720-MHz spectrometer (National
High Magnetic Field Laboratory, Tallahassee, FL). Spectral
assignments were made by using double quantum filtered-
COSY, total correlated spectroscopy, 13C-heteronuclear se-
quential quantum correlation (HSQC), and 15N-HSQC exper-
iments. Distance constraints for structure calculations were
obtained from a series of homonuclear 2D watergate-NOESY
spectra at mixing times ranging from 100 to 400 ms (44). All
spectra were collected with 4,096 points in the acquisition
dimension (signal averaging with 4, 8, or 16 scans) and 128,
256, 400, or 512 points in the indirect dimension. Data were
zero filled to 2K  1K or 2K  512 points before Fourier
transformation. Spectra were referenced at each field by using
an external 2,2-dimethylsilapentane-5-sulfonic acid standard
sample.
Data were transformed by using FELIX 2000 (Accelrys, Inc., San
Diego) and NMRPIPE (45). Peak identification and analysis were
done by using the XEASY and SPARKY programs (46, 47).
Approximate interproton distance restraints were derived in
SPARKY from NOESY spectra, using a Gaussian volume inte-
gration methodology. On the basis of NOE build-up curves, the
peaks were then grouped into three distance ranges of 1.9–2.5 Å,
2.5–3.7 Å, and 3.7–5 Å, corresponding to strong, medium, and
weak NOEs, respectively (48).
Computational Methods. The 3D structure of 1 was constructed
with the SYBYL 6.91 suite of programs. NOEs were then applied
in the form of restraints: interproton distance ranges corre-
sponding to short, medium, and long NOEs were restrained
based on the aforementioned values. The molecule was prepared
for NOE-restrained molecular dynamics simulations. Ensemble-
averaged restrained electrostatic potential (RESP) charges were
determined for each ring. This process consisted of subjecting
the ring to a short molecular dynamics simulation, collecting 25
snapshots, determining the atomic charge of each snapshot by
using the RESP methodology, and finally averaging the charges
over all snapshots. Atomic charges for the peptide were deter-
mined in the same manner. Parameters for the carbohydrate
portion of the molecule were obtained from GLYCAM04, which is
a specialized set of parameters, derived for the accurate simu-
lation of carbohydrates. The rest were treated with parameters
from the PARM99 data set that is part of the AMBER 7 suite of
programs (49). For the simulated annealing runs, the solvent was
treated implicitly as a dielectric continuum by using the Gener-
alized-Born approach (50, 51). An initial annealing simulation
was carried out for several 5-ns periods at 2,000 K, and a series
of snapshots served as initial coordinates for subsequent anneal-
ing runs. A total of 540 simulated annealing trajectories were
carried out. Each consisted of three rounds of the following
sequence. Themolecule was heated to 2,000 K for 10 ps, followed
by 25 ps of dynamics at 2,000 K, and 25 ps of cooling to 0 K. The
final cooling step was carried out for 375 ps. This sequence gave
a total of 530 ps for each run and a combined 286 ns of simulation
for all 540 trajectories. Each conformer was subjected to 10,000
steps of conjugate gradient energy minimization upon comple-
tion of the annealing run, and restraint violation energy was
determined for each of the resulting energy-minimized struc-
tures. The structures were ranked based on the restraint violation
energy. The 50 conformers with the smallest violation energy
were superimposed along the carbon and oxygen atoms of the
saccharide rings. Fig. 1B depicts the 20 structures having the
smallest pairwise rms deviation.
To construct the structure of [NAG-NAM]8 from that of the
experimentally determined 3D structure of compound 1, we
used the program SYBYL 7.0 (Tripos Associates, St. Louis). The
structure extension was performed with one addition of com-
pound 1 to the nascent model at a time with the  and  angles
for the glycosidic torsions conforming to the experimentally
determined values. At each step this was followed by an energy
minimization using the SYBYL TRIPOS force field with Gasteiger
charges. This procedure was repeated until the peptidoglycan
helix contained eight NAG-NAM repeats. The program PYMOL
(www.pymol.org) was then used to create multiple copies of the
helix, which were positioned relative to each other based on the
3-fold symmetry of the helix and the current understanding of
how the peptide stems are cross-linked by transpepdidases based
on available x-ray coordinates. The 3D structure of TolC (Pro-
tein Data Bank ID code 1EK9) was obtained from the Research
Collaboratory for Structural Bioinformatics database (www.rcs-
b.org). The structure was then docked into one of the small pores
of the cell wall model by using SYBYL 7.0. Twenty thousand steps
of steepest decent energy minimization were subsequently car-
ried out by using the TRIPOS force field with Gasteiger charges,
followed by a series of alternating short (10 ps) molecular
dynamics simulations and additional energy minimization steps
to equilibrate the system.
NMR Data. The NMR data for 1 are summarized by peak
assignments with the NOE contacts (Table 1) and the peptide
backbone torsion angles (Table 2).
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